Nuformix (LSE:NFX) Change In Receivables : £0.04 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Nuformix Change In Receivables?

Nuformix's change in receivables for the quarter that ended in Mar. 2024 was £0.04 Mil. It means Nuformix's Accounts Receivable declined by £0.04 Mil from Mar. 2023 to Mar. 2024 .

Nuformix's change in receivables for the fiscal year that ended in Mar. 2022 was £-0.17 Mil. It means Nuformix's Accounts Receivable increased by £0.17 Mil from Mar. 2021 to Mar. 2022 .

Nuformix's Accounts Receivable for the quarter that ended in Mar. 2024 was £0.03 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Nuformix's liquidation value for the six months ended in Mar. 2024 was £-0.05 Mil.

Nuformix Change In Receivables Historical Data

The historical data trend for Nuformix's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Change In Receivables Chart

Nuformix Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Change In Receivables

Get a 7-Day Free Trial

0.08

0.02

0.08

0.05

-0.17

Nuformix Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Mar24
Change In Receivables	Get a 7-Day Free Trial										-0.02	-0.15	-0.06	0.13	0.04

Nuformix Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.04 Mil.

Nuformix (LSE:NFX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Nuformix's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.031	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Nuformix's accounts receivable are only considered to be worth 75% of book value:

Nuformix's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.184	-	0.253	+	0.75 * 0.031	+	0.5 * 0
=	-0.05

Nuformix Change In Receivables Related Terms

Thank you for viewing the detailed overview of Nuformix's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

1RT:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.nuformix.com

Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.